Group One Trading
APLS

Group One Trading’s Apellis Pharmaceuticals APLS Stock Holding History

Group One Trading’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.59M Sell
64,400
-29,500
-31% -$636K 0.01% 1845
2025
Q4 		$2.36M Sell
93,900
-12,700
-12% -$298K ﹤0.01% 2142
2025
Q3 		$2.41M Buy
106,600
+52,100
+96% +$1.22M ﹤0.01% 2123
2025
Q2 		$943K Sell
54,500
-33,700
-38% -$624K ﹤0.01% 2821
2025
Q1 		$1.93M Sell
88,200
-70,000
-44% -$1.93M 0.01% 1839
2024
Q4 		$5.05M Sell
158,200
-77,900
-33% -$2.34M 0.01% 1162
2024
Q3 		$6.81M Buy
236,100
+73,000
+45% +$2.7M 0.02% 826
2024
Q2 		$6.26M Sell
163,100
-102,600
-39% -$4.65M 0.02% 672
2024
Q1 		$15.6M Sell
265,700
-5,600
-2% -$357K 0.06% 257
2023
Q4 		$16.2M Sell
271,300
-158,500
-37% -$8.04M 0.04% 444
2023
Q3 		$16.3M Buy
429,800
+306,500
+249% +$13.5M 0.05% 300
2023
Q2 		$11.2M Buy
123,300
+68,600
+125% +$5.92M 0.04% 452
2023
Q1 		$3.61M Sell
54,700
-121,300
-69% -$7M 0.01% 1054
2022
Q4 		$9.1M Buy
176,000
+111,800
+174% +$5.93M 0.02% 794
2022
Q3 		$4.38M Sell
64,200
-32,600
-34% -$1.93M 0.01% 1267
2022
Q2 		$4.38M Sell
96,800
-50,900
-34% -$2.32M 0.01% 1403
2022
Q1 		$7.5M Buy
147,700
+51,200
+53% +$2.26M 0.01% 1211
2021
Q4 		$4.56M Sell
96,500
-130,200
-57% -$5.13M ﹤0.01% 1783
2021
Q3 		$7.47M Buy
226,700
+191,700
+548% +$10.8M 0.01% 1324
2021
Q2 		$2.21M Buy
35,000
+30,300
+645% +$1.56M ﹤0.01% 2526
2021
Q1 		$202K Sell
4,700
-1,300
-22% -$61.5K ﹤0.01% 5018
2020
Q4 		$343K Buy
+6,000
New +$254K ﹤0.01% 3608
2020
Q3 		– Sell
-6,800
Closed -$222K – 6041
2020
Q2 		$222K Hold
6,800
– – ﹤0.01% 3286
2020
Q1 		$182K Sell
6,800
-14,000
-67% -$497K ﹤0.01% 2830
2019
Q4 		$637K Buy
+20,800
New +$576K ﹤0.01% 2242

Other funds holding APLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Group One Trading's APLS Position: Q4 2025 in Review

Group One Trading sold out of Apellis Pharmaceuticals (APLS) in Q4 2025, closing a stake of 14,925 shares — an estimated $350K sold.

Group One Trading first reported a position in APLS in Q3 2019 and held it in 16 quarters. The position peaked at $15.2M in Q4 2023. 278 funds tracked by Wall St. Rank hold APLS as of Q4 2025.

  • Group One Trading reported no remaining Apellis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 14,925 Apellis Pharmaceuticals shares in Q4 2025, an estimated $350K.
  • Group One Trading first reported a position in Apellis Pharmaceuticals in Q3 2019 and held it in 16 quarters.
  • Group One Trading's Apellis Pharmaceuticals position peaked at $15.2M in Q4 2023.
  • 278 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.